Leslie Holsinger

Track

Insider profile

Currently holds a position at Quince Therapeutics Inc

Positions

Position Company Period
Executive Vice President - Preclinical Development Quince Therapeutics Inc Jan. 1, 2018 -
Vice President - Preclinical Dev. Quince Therapeutics Inc April 1, 2016 - Dec. 1, 2017
Leslie Holsinger's trades of Quince Therapeutics Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2020-12-15 2020-12-14
PlS Planned sale
89,531 +25.0%
34.69
US$3,642,387 		89,531 +25.0% 34.69 US$3,642,387
2020-12-15 2020-12-14
PlS Planned sale
32,001 -26.5%
392.67
US$1,819,481 		32,001 -26.5% 392.67 US$1,819,481
2020-12-15 2020-12-14
PlS Planned sale
99,994 -29.8%
362.50
US$4,922,572 		99,994 -29.8% 362.50 US$4,922,572
2020-12-15 2020-12-14
PlS Planned sale
13,200 -48.0%
30.91
US$408,012 		13,200 -48.0% 30.91 US$408,012
2020-12-15 2020-12-14
PlS Planned sale
14,275 -34.2%
30.15
US$430,391 		14,275 -34.2% 30.15 US$430,391
2020-12-15 2020-12-14
PlS Planned sale
1,700 -3.9%
28.80
US$48,960 		1,700 -3.9% 28.80 US$48,960